UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000018818
Receipt No. R000021766
Scientific Title Trail against hyperlipidemia Patients with high risks to Investigate the effect ON small dense ldl & idl by using middlE dosE rosuvastatin, atrovastatin, psSk-9 inhibitor(relationship of blood ANGPTL, Sortilin, miRNA and so on level) (PIONEERs in Saitama Study 3)
Date of disclosure of the study information 2015/09/14
Last modified on 2018/09/07 18:14:30

No. Disposal Last modified on Item of update
1 Insert 2015/08/26 21:50:38
2 Update 2015/08/28 20:29:30 Narrative objectives1
Narrative objectives1
3 Update 2015/08/28 20:35:29 Narrative objectives1
4 Update 2015/09/14 21:43:18 Public title
Public title
5 Update 2015/09/14 21:52:08 Condition
Primary outcomes
Primary outcomes
6 Update 2015/09/14 22:13:10 Basic design
Control
No. of arms
Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
7 Update 2016/03/26 14:52:50 Recruitment status
8 Update 2016/07/29 18:54:04 Name of primary sponsor
Organization
9 Update 2016/07/29 19:04:52 Public title
Public title
10 Update 2016/07/29 19:11:29 Narrative objectives1
Narrative objectives1
Primary outcomes
Primary outcomes
11 Update 2016/07/29 19:12:36 Public title
12 Update 2016/07/29 19:15:48 Anticipated trial start date
Last follow-up date
13 Update 2016/07/29 19:27:51 No. of arms
Interventions/Control_3
Interventions/Control_3
Target sample size
14 Update 2016/07/29 19:39:48 Public title
15 Update 2016/07/29 19:45:04 Public title
16 Update 2017/09/25 18:48:15 Interventions/Control_3
Interventions/Control_3
Key exclusion criteria
Key exclusion criteria
Target sample size
17 Update 2017/09/25 19:27:00 Narrative objectives1
Narrative objectives1
Key secondary outcomes
Key secondary outcomes
18 Update 2018/02/27 15:24:51 Target sample size
19 Update 2018/02/27 15:25:56 Publication of results
20 Update 2018/08/28 11:56:35 Narrative objectives1
Narrative objectives1
Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
21 Update 2018/08/28 12:05:40 Public title
Public title
22 Update 2018/08/28 12:11:29 Anticipated trial start date
Last follow-up date
Results
Results
23 Update 2018/08/28 13:48:49 Narrative objectives1
Narrative objectives1
Key secondary outcomes
Key secondary outcomes
24 Update 2018/08/28 13:59:01 Key inclusion criteria
Key inclusion criteria
25 Update 2018/08/28 14:02:12 No. of arms
Interventions/Control_4
Interventions/Control_4
26 Update 2018/08/28 14:06:51 Public title
27 Update 2018/08/28 14:09:12 Public title
28 Update 2018/09/07 18:14:30 Public title
Public title
Acronym
Acronym


Contact us.